Additionally, through analysis of TCGA and the Kaplan–Meier Plotter database, we found that breast cancer patients with high PRPF8 expression have a shorter disease-free survival and poorer prognosis, further emphasizing the importance of in-depth research on the relationship between PRPF8 and breast cancer for clinical applications. This evidence concerns the gene PRPF8 and breast carcinoma.